Abstract
The pathomechanism of peroxisomal biogenesis disorders (PBDs), a group of inherited autosomal recessive diseases with mutations of peroxin (PEX) genes, is not yet fully understood. Therefore, several knockout models, e.g., the PEX5 knockout mouse, have been generated exhibiting a complete loss of peroxisomal function. In this study, we wanted to knockdown PEX5 using the siRNA technology (1) to mimic milder forms of PBDs in which the mutated peroxin has some residual function and (2) to analyze the cellular consequences of a reduction of the PEX5 protein without adaption during the development as it is the case in a knockout animal. First, we tried to optimize the transfection of the hepatoma cell line HepG2 with PEX5 siRNA using different commercially available liposomal and non-liposomal transfection reagents (Lipofectamine® 2000, FuGENE 6, HiPerFect®, INTERFERin™, RiboJuice™) as well as microporation using the Neon™ Transfection system. Microporation was found to be superior to the transfection reagents with respect to the transfection efficiency (100 vs. 0–70 %), to the reduction of PEX5 mRNA (by 90 vs. 0–50 %) and PEX5 protein levels (by 70 vs. 0–50 %). Interestingly, we detected that a part of the cleaved PEX5 mRNA still existed as 3′ fragment (15 %) 24 h after microporation. Using microporation, we further analyzed whether the reduced PEX5 protein level impaired peroxisomal function. We indeed detected a reduced targeting of SKL-tagged proteins into peroxisomes as well as an increased oxidative stress as found in PBD patients and respective knockout mouse models. Knockdown of the PEX5 protein and functional consequences were at a maximum 48 h after microporation. Thereafter, the PEX5 protein was resynthesized, which may allow the temporal analysis of the loss as well as the reconstitution of peroxisomes in the future. In conclusion, we propose microporation as an efficient and reproducible method to transfect HepG2 cells with PEX5 siRNA. We succeeded to transiently knockdown PEX5 mRNA and its protein level leading to functional consequences similar as observed in peroxisome deficiencies.
Similar content being viewed by others
Abbreviations
- AP:
-
Alkaline phosphatase
- Bp:
-
Base pairs
- MEM:
-
Minimum Essential Medium
- Neg siRNA:
-
Silencer™ negative control siRNA
- Nt:
-
Nucleotide(s)
- PBD:
-
Peroxisomal biogenesis disorder
- PBS:
-
Phosphate-buffered saline
- PEX:
-
Peroxin (peroxisomal biogenesis protein)
- PEX5:
-
Human peroxisomal biogenesis factor 5 protein
- PEX5 :
-
Human peroxisomal biogenesis factor 5 gene
- PEX5 split:
-
PEX5 PCR primer complementary to the PEX5 siRNA cleavage site
- PEX5 3′ end:
-
PEX5 PCR primer complementary to the 3′ fragment of the PEX5 siRNA cleavage
- PTS1:
-
Peroxisomal targeting signal 1
- PTS2:
-
Peroxisomal targeting signal 2
- RISC:
-
RNA-induced silencing complex
- ROS:
-
Reactive oxygen species
- RT-PCR:
-
Reverse transcriptase polymerase chain reaction
- SKL:
-
Serine–lysine–leucine–COOH at the C-terminus
- TBS:
-
Tris-buffered saline
- TBST:
-
Tris-buffered saline plus 0.05 % Tween 20
References
Ahlemeyer B, Gottwald M, Baumgart-Vogt E (2012) Deletion of a single allele of the Pex11β gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain. Dis Model Mech 5:125–140
Ammerschlaeger M, Beigel J, Klein KU, Mueller SO (2004) Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes. Toxicol Sci 78:229–240
Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, Van Veldhoven PP, Mannaerts GP (1997) A mouse model for Zellweger syndrome. Nat Genet 17:49–57
Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq PE, Fahimi HD, Baes M (2001) Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (Pex5 knockout mouse). Am J Pathol 159:1477–1494
Baumgart E, Fahimi HD, Steininger H, Grabenbauer M (2003) A review of morphological techniques for detection of peroxisomal (and mitochondrial) proteins and their corresponding mRNAs during ontogenesis in mice: application to the PEX5-knockout mouse with Zellweger syndrome. Microsc Res Tech 61:121–138
Berg K, Selbo PK, Prasmickaite L, Tjelle TE, Sandvig K, Moan J, Gaudernack G, Fodstad O, Kjølsrud S, Anholt H, Rodal GH, Rodal SK, Høgset A (1999) Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res 59:1180–1183
Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254
Braverman N, Dodt G, Gould SJ, Valle D (1998) An isoform of pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes. Hum Mol Genet 7:1195–1205
Byron M, Pallotta V, Brown B, Ford L (2002) Visualizing siRNA in mammalian cells: fluorescence analysis of the RNAi effect. Ambion TechNotes 9:68
Dai J, Rabie AB (2007) The use of recombinant adeno-associated virus for skeletal gene therapy. Orthod Craniofac Res 10:1–14
Dirkx R, Vanhorebeek I, Martens K, Schad A, Grabenbauer M, Fahimi D, Declercq P, Van Veldhoven PP, Baes M (2005) Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology 41:868–878
Dodt G, Braverman N, Wong C, Moser A, Moser HW, Watkins P, Valle D, Gould SJ (1995) Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet 9:115–125
Dominska M, Dykxhoorn DM (2010) Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci 123:1183–1189
Dunne J, Drescher B, Riehle H, Hadwiger P, Young BD, Krauter J, Heidenreich O (2003) The apparent uptake of fluorescently labeled siRNAs by electroporated cells depends on the fluorochrome. Oligonucleotides 13:375–380
Ebadi P, Karimi MH, Pourfathollah AA, Saheb GLA, Soheili ZS, Samiee S, Hajati S, Nadali F, Geramizadeh B, Moazzeni SM (2009) The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6. Iran J Immunol 6:1–11
El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, Alvarez-Erviti L, Sargent IL, Wood MJ (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112–2126
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
Espeel M, Poggi F, Roels F, Saudubray J (1993) Cytoplasmic catalase but correct localization of four peroxisomal enzymes in the liver of a child with several peroxisomal dysfunctions. Eur J Cell Biol 60:74
Filipowicz W (2005) RNAi: the nuts and bolts of the RISC machine. Cell 122:17–20
Fritsch L, Martinez LA, Sekhri R, Naguibneva I, Gérard M, Vandromme M, Schaeffer L, Harel-Bellan A (2004) Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep 5:178–182
Gao S, Seker E, Casali M, Wang F, Bale SS, Price GM, Yarmush ML (2012) Ex vivo gene delivery to hepatocytes: techniques, challenges, and underlying mechanisms. Ann Biomed Eng 40:1851–1861
Grant P, Ahlemeyer B, Karnati S, Berg T, Stelzig I, Nenicu A, Kuchelmeister K, Crane DI, Baumgart-Vogt E (2013) The biogenesis protein PEX14 is an optimal marker for the morphological localization of peroxisomes in different cell types, tissues and species. Histochem Cell Biol 140:423–442
Grünweller A, Gillen C, Erdmann VA, Kurreck J (2003) Cellular uptake and localization of a Cy3-labeled siRNA specific for the serine/threonine kinase Pim-1. Oligonucleotides 13:345–352
Hamm A, Krott N, Breibach I, Blindt R, Bosserhoff AK (2002) Efficient transfection method for primary cells. Tissue Eng 8:235–245
Hammond SM (2005) Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett 579:5822–5829
Heidel JD (2011) Cyclodextrin-containing polycations for nucleic acid delivery. Cold Spring Harb Protoc 2011:1319–1322
Hohsfield LA, Geley S, Reindl M, Humpel C (2013) The generation of NGF-secreting primary rat monocytes: a comparison of different transfer methods. J Immunol Methods 391:112–124
Jacobsen LB, Calvin SA, Colvin KE, Wright M (2004) FuGENE 6 transfection reagent: the gentle power. Methods 33:104–112
Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, Daniel WL, Scott AW, Rotz MW, Meade TJ, Giljohann DA, Mirkin CA, Stegh AH (2013) Spherical nucleic acid nanoparticle conjugates as an RNAi-Based therapy for glioblastoma. Sci Transl Med 5:209ra152
Judge A, MacLachlan I (2008) Overcoming the innate immune response to small interfering RNA. Hum Gene Ther 19:111–124
Kandan-Kulangara F, Shah RG, el Affar B, Shah GM (2010) Persistence of different forms of transient RNAi during apoptosis in mammalian cells. PLoS One 5:e12263
Karnati S, Baumgart-Vogt E (2009) Peroxisomes in airway epithelia and future prospects of these organelles for pulmonary cell biology. Histochem Cell Biol 131:447–454
Kawada Y, Khan M, Sharma AK, Ratnayake DB, Dobashi K, Asayama K, Moser HW, Contreras MA, Singh I (2004) Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients. Mol Genet Metab 83:297–305
Kim TK, Eberwine JH (2010) Mammalian cell transfection: the present and the future. Anal Bioanal Chem 397:3173–3178
Kraus A, Täger J, Kohler K, Haerle M, Werdin F, Schaller HE, Sinis N (2010) Non-viral genetic transfection of rat Schwann cells with FuGENE HD© lipofection and AMAXA© nucleofection is feasible but impairs cell viability. Neuron Glia Biol 6:225–230
Lefebvre B, Vandewalle B, Longue J, Moerman E, Lukowiak B, Gmyr V, Maedler K, Kerr-conte J, Pattou F (2010) Efficient gene delivery and silencing of mouse and human pancreatic islets. BMC Biotechnol 10:28–33
Marucci G, Lammi C, Buccioni M, Dal Ben D, Lambertucci C, Amantini C, Santoni G, Kandhavelu M, Abbracchio MP, Lecca D, Volpini R, Cristalli G (2011) Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1. Anal Biochem 414:300–302
Nguyen T, Bjorkman J, Paton BC, Crane DI (2006) Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance. J Cell Sci 119:636–645
Orban TI, Izaurralde E (2005) Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 11:459–469
Otera H, Harano T, Honsho M, Ghaedi K, Mukai S, Tanaka A, Kawai A, Shimizu N, Fujiki Y (2000) The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates the Pex7p-PTS2 protein complex into peroxisomes via its initial docking site, Pex14p. J Biol Chem 275:21703–21714
Pampinella F, Lechardeur D, Zanetti E, MacLachlan I, Benharouga M, Lukacs GL, Vitiello L (2002) Analysis of differential lipofection efficiency in primary and established myoblasts. Mol Ther 5:161–169
Parker R, Song H (2004) The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 11:121–127
Petriv OI, Pilgrim DB, Rachubinski RA, Titorenko VI (2002) RNA interference of peroxisome-related genes in C. elegans: a new model for human peroxisomal disorders. Physiol Genomics 10:79–91
Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11:499–505
Rabie AB, Dai J, Xu R (2007) Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth. Gene Ther 14:972–980
Rao DD, Vorhies JS, Senzer N, Nemunaitis J (2009) siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 61:746–759
Rizk A, Rabie BM (2013) Electroporation for transfection and differentiation of dental pulp stem cells. Biores Open Access 2:155–162
Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW (2006) Peroxisome biogenesis disorders. Biochim Biophys Acta 1763:1733–1748
Stier H, Fahimi HD, Van Veldhoven PP, Mannaerts GP, Völkl A, Baumgart E (1998) Maturation of peroxisomes in differentiating human hepatoblastoma cells (HepG2): possible involvement of the peroxisome proliferator-activated receptor alpha (PPAR alpha). Differentiation 64:55–66
Subramanian A, Ranganathan P, Diamond SL (1999) Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat Biotechnol 17:873–877
Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346–358
Tietz SM, Berghoff M (2012) Gene silencing of MK2 in hard-to-transfect human U937 cells. Biomol Tech 23:47–50
Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD (2004) A protein sensor for siRNA asymmetry. Science 306:1377–1380
Tsutsumi T, Hirayama F, Uekama K, Arima H (2007) Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). J Control Release 119:349–359
Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515–524
Wang B, Van Veldhoven PP, Brees C, Rubio N, Nordgren M, Apanasets O, Kunze M, Baes M, Agostinis P, Fransen M (2013) Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radic Biol Med 65C:882–894
Yalvac ME, Ramazanoglu M, Gumru OZ, Sahin F, Palotás A, Rizvanov AA (2009) Comparison and optimisation of transfection of human dental follicle cells, a novel source of stem cells, with different chemical methods and electroporation. Neurochem Res 34:1272–1277
Yamano S, Dai J, Moursi AM (2010) Comparison of transfection efficiency of nonviral gene transfer reagents. Mol Biotechnol 46:287–300
Yuan J, Wang X, Zhang Y, Hu X, Deng X, Fei J, Li N (2006) shRNA transcribed by RNA Pol II promoter induce RNA interference in mammalian cell. Mol Biol Rep 33:43–49
Zeitelhofer M, Karra D, Vessey JP, Jaskic E, Macchi P, Thomas S, Riefler J, Kiebler M, Dahm R (2009) High-efficiency transfection of short hairpin RNAs-encoding plasmids into primary hippocampal neurons. J Neurosci Res 87:289–300
Zhang J, Zheng N, Zhou P (2003) Exploring the functional complexity of cellular proteins by protein knockout. Proc Natl Acad Sci USA 100:14127–14132
Acknowledgments
The authors would like to thank Georg Lüers, Saba Hadad and Srikanth Karnati for their recommendation to use the Neon™ Transfection System as well as Gabriele Thiele and Andrea Textor for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ahlemeyer, B., Vogt, JF., Michel, V. et al. Microporation is an efficient method for siRNA-induced knockdown of PEX5 in HepG2 cells: evaluation of the transfection efficiency, the PEX5 mRNA and protein levels and induction of peroxisomal deficiency. Histochem Cell Biol 142, 577–591 (2014). https://doi.org/10.1007/s00418-014-1254-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-014-1254-6